Between April 2005 and December 2005, 216 patients (142 inpatients and 74 outpatients) from ten hospitals were enrolled. There were 126 male and 90 female patients (a ratio of 1.4:1). Of the 216 ...
Soleno intends to submit plans to FDA to conduct further analyses of clinical data from completed and ongoing studies of DCCR, together with external, natural history studies REDWOOD CITY, Calif., Dec ...
Please provide your email address to receive an email when new articles are posted on . Two presentations at the 2018 Foundation for Prader-Willi Research Annual Conference in Las Vegas detailed ...
REDWOOD CITY, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment ...
BEIJING, July 30 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (BULLETIN BOARD: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed ...
New Delhi: Researchers at Indian Institute of Technology Hyderabad have developed a method to produce controlled-release oral tablets by loading the drug molecules onto a base that dissolves gradually ...
Background and Objective: Oxycodone is a semisynthetic opioid analgesic drug classed as a strong opioid. The controlled-release oxycodone tablet formulation (OCRT) was approved in China in 2004 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback